Healthcare >> Analyst Interviews >> May 8, 2002

Biotechnology Stocks: Eric Schmidt – Sg Cowen Securities Corporation

ERIC SCHMIDT is a Managing Director and Senior Research Analyst at SG Cowen Securities. He joined SG Cowen in 1998 and has been covering biotechnology stocks for eight years. He was a runner-up in biotechnology in the 2001 and 2002 Institutional Investor survey. He was previously a Vice President and Research Analyst for UBS Securities. Before joining UBS, he co-founded Cambridge Biological Consultants, a scientific consulting and research firm. He holds a BA in Chemistry from the University of Pennsylvania and a PhD in Biochemistry from the Massachusetts Institute of Technology. Profile
TWST: Could we start out with your view of what's going on in

biotech? It has been a very busy, high profile area as of late.

What's happening?

Mr. Schmidt: I think we finally figured out what